UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
(Exact Name of Registrant as Specified in Charter)
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| (Address of Principal Executive Offices) | (Zip Code) |
(Registrant’s telephone number, including area code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act: None
| Title of each class |
Trading |
Name of each exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
| Item 3.02. | Unregistered Sales of Equity Securities. |
On July 1, 2025, EQT Private Equity Company LLC (the “Company”) sold unregistered shares (the “Investor Shares”) of the Company to third party investors for cash for aggregate consideration of approximately $86,683,778, at a price per Investor Share of $25.00. The following table provides details on the Investor Shares sold by the Company:
| Class |
Number of Shares Sold(1) | Aggregate Consideration(1) | ||||||
| Class I Shares |
400 | $ | 10,000 | |||||
| Class A-I Shares |
433,552 | $ | 10,838,800 | |||||
| Class A-D Shares |
400,000 | $ | 10,000,000 | |||||
| Class A-J1 Shares |
2,294,720 | $ | 57,368,000 | |||||
| Class A-J2 Shares |
338,679 | $ | 8,466,978 | |||||
| (1) | Share and dollar amounts are rounded to the nearest whole number. |
In addition, on July 1, 2025, the Company issued to EQT Holdings AB, an indirect subsidiary of EQT AB, a total of 804,000 Class E Shares of the Company (the “Class E Shares”), valued at $25.00 per Class E Share, in exchange for the contribution to the Company of ownership interests in GeBBS Healthcare Solutions Private Limited, a healthcare revenue cycle management services provider.
The offer and sale of the Investor Shares and Class E Shares were exempt from the registration provisions of the Securities Act of 1933, as amended, by virtue of Section 4(a)(2), including Regulation D (for sales to accredited investors) and/or Regulation S (for sales to non-U.S. investors outside of the United States) thereunder.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| EQT Private Equity Company LLC | ||
| By: | /s/ Bethany Oleynick | |
| Name: | Bethany Oleynick | |
| Title: | Legal Director and Secretary | |
Date: July 2, 2025